Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Scally

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Langenbeck'S Archives of Surgery|February 28, 2023
Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasmsDerek J Erstad, Kristen A Robinson, Karen Beaty, et al.
Surgical Oncology|September 6, 2020
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approachChing-Wei D Tzeng, Hop S Tran Cao, Christina L Roland, et al.
Annals of Surgical Oncology|October 23, 2023
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable BenefitNeal Bhutiani, Travis E Grotz, Seth J Concors, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
JAMA Network Open|March 18, 2021
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020Jace P Landry, Kelsey L Schertz, Yi-Ju Chiang, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Annals of Surgical Oncology|February 23, 2024
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue SarcomaRaymond S Traweek, Heather G Lyu, Russell G Witt, et al.
Surgery Open Science|June 6, 2022
A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patientsTimothy P DiPeri, Timothy E Newhook, Ryan W Day, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology|November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trialB Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Langenbeck'S Archives of Surgery|February 28, 2023
Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasmsDerek J Erstad, Kristen A Robinson, Karen Beaty, et al.
Surgical Oncology|September 6, 2020
Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approachChing-Wei D Tzeng, Hop S Tran Cao, Christina L Roland, et al.
Annals of Surgical Oncology|October 23, 2023
Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable BenefitNeal Bhutiani, Travis E Grotz, Seth J Concors, et al.
Annals of Surgical Oncology|February 1, 2023
Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society MembershipRussell G Witt, Rachel K Voss, Yi-Ju Chiang, et al.
JAMA Network Open|March 18, 2021
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020Jace P Landry, Kelsey L Schertz, Yi-Ju Chiang, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Annals of Surgical Oncology|February 23, 2024
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue SarcomaRaymond S Traweek, Heather G Lyu, Russell G Witt, et al.
Surgery Open Science|June 6, 2022
A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patientsTimothy P DiPeri, Timothy E Newhook, Ryan W Day, et al.
Cancer|August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomesAndrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology|November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trialB Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Pageof 7